In the Maury lab, we are interested in host-pathogen interactions in the context of Ebola virus infection. I'm particularly interested in studying the complex role of interferons, a class of cytokines, in both innate and adaptive immune responses to Ebola virus and the licensed Ebola virus vaccine.

Publications:

Elliff JM, Van Ert H, Sevcik K, Djurkovic MA, Rudd D, Gourronc F, Klingelhutz A,
Shtanko O, Maury W. Interferons inhibit Ebola virus infection of human keratinocytes. Viruses. In Press Dec 2025.

Aguilar-Briseño JA, Elliff JM, Patten JJ, Wilson LR, Davey RA, Bailey AL, Maury W. Effect of Interferon Gamma on Ebola Virus Infection of Primary Kupffer Cells and a Kupffer Cell Line. Viruses 2023, 15, 2077. PMID: 37896854

Bohan D, Van Ert H, Ruggio N, Rogers KJ, Badreddine M, Aguilar Briseño JA, Elliff JM, Rojas Chavez RA, Gao B, Stokowy T, Christakou E, Kursula P, Micklem D, Gausdal G, Haim H, Minna J, Lorens JB, Maury W. Phosphatidylserine receptors enhance SARS-CoV-2 infection. PLoS Pathog. 2021 Nov 19;17(11):e1009743. doi: 10.1371/journal.ppat.1009743. PMID: 34797899; PMCID: PMC8641883.

Messingham KN, Richards PT, Fleck A, Patel RA, Djurkovic M, Elliff J, Connell S, Crowe TP, Munoz Gonzalez J, Gourronc F, Dillard JA, Davey RA, Klingelhutz A, Shtanko O, Maury W. Multiple cell types support productive infection and dynamic translocation of infectious Ebola virus to the surface of human skin. Sci Adv. 2025 Jan 3;11(1):eadr6140. doi: 10.1126/sciadv.adr6140. Epub 2025 Jan 1. PMID: 39742475; PMCID: PMC11691639.